靶向BRD4的ATTECs设计、合成与降解活性研究
投稿时间:2022-06-13  修订日期:2022-10-10  点此下载全文
引用本文:周洛竹,盛春泉.靶向BRD4的ATTECs设计、合成与降解活性研究[J].药学实践杂志,2023,41(1):18~25
摘要点击次数: 504
全文下载次数: 917
作者单位E-mail
周洛竹 海军军医大学药学系药物化学教研室, 上海200433  
盛春泉 海军军医大学药学系药物化学教研室, 上海200433 shengcq@smmu.edu.cn 
基金项目:国家自然科学基金(82030105)
中文摘要:目的 基于自噬小体绑定化合物(ATTEC)策略,设计并合成靶向BRD4的自噬降解剂,验证其降解活性。方法 以化合物伊斯平斯(ispinesib)为LC3配体,通过不同长度的linker与化合物JQ1相连,产物结构经1H NMR、13C NMR与 ESI-MS确证,并使用蛋白印迹法(Western Blot)技术测试其在不同细胞系中诱导BRD4的降解活性。结果 获得5个首次报道的BRD4-ATTEC分子,化合物4在不同细胞系中显示出一定的BRD4降解活性。结论 本研究发现了新型BRD4自噬降解剂,拓展了靶向自噬降解的适用范围。
中文关键词:自噬小体绑定化合物  BRD4  LC3蛋白  伊斯平斯
 
Design, synthesis and degradation activity of BRD4-targeting ATTECs
Abstract:Objective To design and synthesize autophagic degraders targeting BRD4 based on autophagosome tethering compound (ATTEC) strategy and test their BRD4 degradation activity. Methods BRD4-targeting ATTECs were constructed by conjugating ispinesib that used as a LC3 ligand and JQ1 through a variety of alkane linkers. The final compounds were confirmed by 1H NMR, 13C NMR and ESI-MS, and their degradation activity in different cell lines were tested by Western Blot. Results Five BRD4-ATTEC molecules were successfully synthesized for the first time. Compound 4 showed moderate BRD4 degradation activity in different cell lines. Conclusion The novel BRD4 autophagic degraders were discovered, which expanded the applicability of targeted autophagic degradation via ATTEC.
keywords:autophagosome-tethering compounds  BRD4  LC3  Ispinesib
查看全文  查看/发表评论  下载PDF阅读器
关闭

分享按钮